Texas § 549.0312 PUBLIC DISCLOSURE OF CERTAIN BOARD RECOMMENDATIONS REQUIRED.

Texas Statutes

§ 549.0312 — PUBLIC DISCLOSURE OF CERTAIN BOARD RECOMMENDATIONS REQUIRED.

Texas § 549.0312

Code GVGovernment Code

This text of Texas § 549.0312 (PUBLIC DISCLOSURE OF CERTAIN BOARD RECOMMENDATIONS REQUIRED.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Government Code Code Ann. § 549.0312 (2026).

Text

Sec. 549.0312. PUBLIC DISCLOSURE OF CERTAIN BOARD RECOMMENDATIONS REQUIRED.

(a)The commission or the commission's agent shall publicly disclose, immediately after the board's deliberations conclude, each specific drug recommended for or against preferred drug list status for each drug class included in the preferred drug list for the Medicaid vendor drug program. The disclosure must include:

(1)the general basis for the recommendation for each drug class; and

(2)for each recommendation, whether a supplemental rebate agreement or program benefit agreement was reached under Subchapter C.

(b)The disclosure must be posted on the commission's Internet website not later than the 10th business day after the date of conclusion of board deliberations that result in recommendations made to the e

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 549.0312. PUBLIC DISCLOSURE OF CERTAIN BOARD RECOMMENDATIONS REQUIRED. (a) The commission or the commission's agent shall publicly disclose, immediately after the board's deliberations conclude, each specific drug recommended for or against preferred drug list status for each drug class included in the preferred drug list for the Medicaid vendor drug program. The disclosure must include:
(1) the general basis for the recommendation for each drug class; and
(2) for each recommendation, whether a supplemental rebate agreement or program benefit agreement was reached under Subchapter C.
(b) The disclosure must be posted on the commission's Internet website not later than the 10th business day after the date of conclusion of board deliberations that result in recommendations made to the executive commissioner regarding the placement of drugs on the preferred drug list.
SUBCHAPTER H. MEDICAID DRUG UTILIZATION REVIEW PROGRAM